Kenkare-Mitra Sara 4
4 · Unicycive Therapeutics, Inc. · Filed Jul 30, 2025
Insider Transaction Report
Form 4
Kenkare-Mitra Sara
Director
Transactions
- Award
Stock Options
2025-07-28+21,200→ 39,200 totalExercise: $4.71From: 2026-07-28Exp: 2035-07-28→ Common Stock (21,200 underlying)